Fundraising Fox

Rhythm Pharmaceuticals

NASDAQ: RYTM

Boston, US · Founded 2013 · Delaware corporation · 4 known investors

Biotech

Founders & leadership

ET
Edward T. MathersDirector
DJ
David J. McGirrDirector
JS
Jonathan SilversteinDirector
KG
Keith GottesdienerExecutive Officer, Director
DP
David P. Meeker, M.D.Director
NE
Neil ExterDirector
BH
Bart HendersonMr. Henderson is the President and Treasurer of the Issuer.
TF
Todd FoleyDirector
CJ
Christophe JeanDirector

Investors · 4

Foresite CapitalLarkspur
New Enterprise Associates (NEA)reportedMenlo Park · $200K – $40M
OrbiMedreportedNew York · $1M – $75Mvia Jonathan Silverstein · board
Third Rock VenturesreportedBoston · $100K – $5Mvia Neil Exter · board

Reported raises · per SEC filings

Form D private placements
▶$20.5MraisedJan 2017 · 14 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • David P. Meeker, M.D.Director
  • Neil ExterDirector
  • David J. McGirrDirector
  • Jonathan SilversteinDirector
  • Edward T. MathersDirector
  • Christophe JeanDirector
  • Bart HendersonExecutive Officer, Promoter
  • Todd FoleyDirector
  • Keith GottesdienerExecutive Officer, Director, Promoter
Offering amount
$40.9M
Amount sold
$20.5M
First sale
Jan 2017
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$40MraisedDec 2015 · 12 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Edward T. MathersDirector
  • David J. McGirrDirector
  • Jonathan SilversteinDirector
  • Keith GottesdienerExecutive Officer, Director
  • David P. Meeker, M.D.Director
  • Neil ExterDirector
  • Bart HendersonExecutive Officer
  • Todd FoleyDirector
  • Christophe JeanDirector
Offering amount
$40M
Amount sold
$40M
First sale
Aug 2015
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.